News About: Pharm. Industry
New Hanmi advisor starts work
Hanmi Pharm said that Kim Chung-soo Mellve, former president of Korea Pharmaceutical Manufacturers Association, has been named as its new advisor.
Kim is starting work at Hanmi Pharm from March 18, according to the...
Samil, Boehringer Ingelheim sign exclusive distribution agreement over Mobic cap.
Samil Pharm has signed an exclusive distribution agreement with Boeringer Ingelheim Korea to supply Mobic (meloxicma) in the domestic market.
“We are excited to enter into this collaboration with Boehringer Ingelhe...
Hanmi releases dexibuprofen ER tablets
Hanmi Pharm said it has newly launched an extended release form of dexibuprofen 300 mg tablets for relief of sign and symptoms of osteoarthritis, rheumatoidal disorders such as osseous rheumatism, ankylosing spondilit...
Daewoong launches Fiblast spray
Daewoong Pharm said it has launched Fiblast Spray (trafermin) for treatment of skin ulcers and decubitus.
The active ingredient in Fiblast Spray is recombinant basic Fibroblast Growth Factor (FGF), which the Japane...
New CEOs in pharmaceutical industry facing challenge
Local pharmaceutical firms are likely to face their biggest challenges this year due to the deepening economic downturn; so too will be heads of the leading pharmaceutical firms.
Experts said a number of newly app...
Sales managers pressed to boost sales
Top sales managers in pharmaceutical firms are busy providing both hospitals and individual doctors with various sweeteners including rebates, contributions and payments of expenses for overseas trips for using their ...
Drugmakers rushing to OTC price increase race
Influenced by weakening domestic demand amid the deepening global economic downturn, the Korean OTC makers plan to increase the price of their flagship products despite concern over consumers’ antipathy.
Leading OT...
Korea Bone Bank gets investment from ePlanet Ventures
ePlanet Ventures, the world’s leading global venture capital firm headquartered in Silicon Valley, California, announced on March 14 a total of $6 million B investment in Korea Bone Bank.
Commenting on the occasio...
Kim Yoon-seob, Choi Sang-hoo elected as Yuhan presidents
Yuhan Corporation elected Kim Yoon-seob and Choi Sang-hoo as new chief executive officers of the company at the general shareholders meeting on March 13 at its head office in Seoul.
A graduate of ChungAng Universit...
Controversy brewing over Pharmaceutical Promotion Act
A controversy surrounding the enforcement of the Pharmaceutical Promotion Act is growing.
In a recent forum organized by a lawmaker, bioventure officials and some private economists argued that the special law shou...
